A detailed history of Armstrong Advisory Group, Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Armstrong Advisory Group, Inc holds 441 shares of NVO stock, worth $49,943. This represents 0.0% of its overall portfolio holdings.

Number of Shares
441
Previous 1,028 57.1%
Holding current value
$49,943
Previous $146,000 64.38%
% of portfolio
0.0%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

SELL
$119.07 - $145.42 $69,894 - $85,361
-587 Reduced 57.1%
441 $52,000
Q2 2024

Jul 12, 2024

BUY
$122.71 - $146.91 $126,145 - $151,023
1,028 New
1,028 $146,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $256B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Armstrong Advisory Group, Inc Portfolio

Follow Armstrong Advisory Group, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Armstrong Advisory Group, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Armstrong Advisory Group, Inc with notifications on news.